Yun Wan Su, Yang Wonseok, Shim Man Kyu, Song Sukyung, Choi Jiwoong, Kim Jeongrae, Kim Jinseong, Moon Yujeong, Jo SeongHoon, Lim Dong-Kwon, Kim Kwangmeyung
College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.
Biomater Res. 2024 Apr 29;28:0024. doi: 10.34133/bmr.0024. eCollection 2024.
Photothermal therapy (PTT) at mild temperatures ranging from 44 to 45 °C holds tremendous promise as a strategy for inducing potent immunogenic cell death (ICD) within tumor tissues, which can reverse the immunosuppressive tumor microenvironment (ITM) into an immune-responsive milieu. However, accurately and precisely controlling the tumor temperature remains a formidable challenge. Here, we report the precision photothermal immunotherapy by using silica-coated gold nanorods (AuNR@SiO), and investigating the optimal administration routes and treatment protocols, which enabled to achieve the sustained and controlled mild heating within the tumor tissues. First, the highest photothermal performance of AuNR@SiO with 20-nm silica shell thickness than 5 or 40 nm was confirmed in vitro and in vivo. Then, the optimal conditions for precision immunotherapy were further investigated to produce mild temperature (44 to 45 °C) accurately in tumor tissues. The optimal conditions with AuNR@SiO result in a distinct cell death with high early/late apoptosis and low necrosis, leading to very efficient ICD compared to lower or higher temperatures. In colon tumor-bearing mice, intratumorally injected AuNR@SiO efficiently promotes a mild temperature within the tumor tissues by local irradiation of near-infrared (NIR) laser. This mild PTT substantially increases the population of mature dendritic cells (DCs) and cytotoxic T cells (CTLs) within tumor tissues, ultimately reversing the ITM into an immune-responsive milieu. Furthermore, we found that the combination mild PTT with AuNR@SiO and anti-PD-L1 therapy could lead to the 100% complete regression of primary tumors and immunological memory to prevent tumor recurrence. Collectively, this study demonstrates that AuNR@SiO with a robust methodology capable of continuously inducing mild temperature accurately within the ITM holds promise as an approach to achieve the precision photothermal immunotherapy.
在44至45°C的温和温度下进行光热疗法(PTT)作为一种在肿瘤组织内诱导强效免疫原性细胞死亡(ICD)的策略具有巨大潜力,这可以将免疫抑制性肿瘤微环境(ITM)转变为免疫反应性环境。然而,准确且精确地控制肿瘤温度仍然是一项艰巨的挑战。在此,我们报告了通过使用二氧化硅包覆的金纳米棒(AuNR@SiO)进行精确光热免疫疗法,并研究了最佳给药途径和治疗方案,从而能够在肿瘤组织内实现持续且可控的温和加热。首先,在体外和体内证实了二氧化硅壳厚度为20 nm的AuNR@SiO比5 nm或40 nm具有最高的光热性能。然后,进一步研究了精确免疫疗法的最佳条件,以在肿瘤组织中准确产生温和温度(44至45°C)。与较低或较高温度相比,AuNR@SiO的最佳条件导致明显的细胞死亡,早期/晚期凋亡率高且坏死率低,从而产生非常有效的ICD。在荷结肠肿瘤小鼠中,瘤内注射AuNR@SiO通过近红外(NIR)激光局部照射有效地促进肿瘤组织内的温和温度。这种温和的PTT显著增加了肿瘤组织内成熟树突状细胞(DCs)和细胞毒性T细胞(CTLs)的数量,最终将ITM转变为免疫反应性环境。此外,我们发现温和的PTT与AuNR@SiO和抗PD-L1疗法相结合可导致原发性肿瘤100%完全消退并产生免疫记忆以防止肿瘤复发。总体而言,这项研究表明,具有强大方法的AuNR@SiO能够在ITM内持续准确地诱导温和温度,有望成为实现精确光热免疫疗法的一种方法。